Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback